Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN) Social Stream



Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN): $46.57

0.26 (-0.56%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add BHVN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#272 of 332

in industry

Featured Post From StockTwits About BHVN

$BHVN
95% migraine patients can take Nurtec for acute or chronic use

$800 per rx

12.8% prevalence rate in america

with some worst case assumptions:
30% chronic, 70% acute
only 1 rx for acute per year

10% of migraine patients taking it
cut the price of rx by 50%.. $400

quick math shows over $7 billion revenue yes BILLION

now try to do more realistic assumptions and add other pipeline stocks in coming years

do you now see $500 to $800 stock price here?

97% float is own by institutions

There is no shares avail. stock can do +/- $10 in minutes with small sell/buy orders.

accumulate as much as you can. Hope we see $80s and $90s.
haikaa, published August 10, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!